← Back to Dashboard

Inosine (Inosine pranobex)

Stimulates cell-mediated immune response

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

CC(CN(C)C)O.CC(CN(C)C)O.CC(CN(C)C)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.CC(=O)N…
YLDCUKJMEKGGFI-QCSRICIXSA-N

Clinical Development by Virus19

Human papillomavirus
HPV
Target: Viral DNA pol
FDA approved
Preclinical
Phase 2positive
Phase 3positive
Approved
FDA
Human alphaherpesvirus 1
HSV-1
Target: Viral DNA pol
FDA approved
Preclinical
Phase 2positive
Phase 3positive
Approved
FDA
Human alphaherpesvirus 2
HSV-2
Target: Viral DNA pol
FDA approved
Preclinical
Phase 2positive
Phase 3positive
Approved
FDA
Human immunodeficiency virus 1
HIV-1
Target: Viral RT
Phase 3
Preclinical
Phase 2
Phase 3
Approved
Rhinovirus A
HRV-A21
Target: Viral RNA pol
Phase 2
Preclinical
Phase 2
Phase 3
Approved
Influenza A virus
FLUAV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Hepatitis B virus
HBV
Target: Viral RT
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Measles morbillivirus
MeV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Vaccinia virus
VACV
Target: Viral DNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human alphaherpesvirus 3
VZV
Target: Viral DNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Rabies lyssavirus
RABV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Enterovirus A
CV-A16
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Cardiovirus A
EMCV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human mastadenovirus C
HAdV-2
Target: Viral DNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human mastadenovirus C
HAdV-5
Target: Viral DNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Hepatovirus A
HAV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Enterovirus A
EV-A71
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human orthorubulavirus 4
HPIV-4
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Rotavirus A
RoV-SA11
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved